Grifols, S.A. DIO Ratio 2011-2026 | GRFS

Annual DIO Ratio Grifols, S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	0.000171	261	263	275	282	-

All numbers in EUR currency

Maximum	Minimum	Average
282	0.000171	216

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
Aptorum Group Limited APM	4.89	$ 0.79	-1.15 %	$ 4.31 M	China
Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
ADMA Biologics ADMA	316	$ 15.36	-2.17 %	$ 3.66 B	USA
Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
Anika Therapeutics ANIK	247	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	181	$ 74.36	-1.64 %	$ 1.44 B	USA
AVEO Pharmaceuticals AVEO	63.8	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	168	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	892	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	233	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	644	$ 61.3	1.21 %	$ 11.8 B	USA
Codexis CDXS	50.2	$ 1.23	-2.38 %	$ 90.3 M	USA
Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA